Description
Uses of Medicine:
Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Patients, Healthcare Professionals (HCPs), or Hospitals can buy Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg online from India through THE INDIAN PHARMA (a trusted Mounjaro Supplier, Exporter, and Contract Manufacturer in India) for the:- management of type 2 diabetes (T2D) mellitus in adults to improve glycemic control as an adjunct to diet and exercise.
- support in weight loss management for adults with obesity or overweight conditions, particularly those with related comorbidities.
Limitations of Use:
Individuals with a BMI more than 27.5 Kg/m2 can be eligible for Mounjaro and those with a BMI more than 25 Kg/m2 with obesity-related complications like diabetes etc. can be eligible under medical supervision. Mounjaro has not been studied in patients with a history of pancreatitis. It is not indicated for use in patients with type 1 diabetes mellitus.Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg injection is primarily used to manage blood sugar levels in adult individuals with type 2 diabetes (T2D). This injectable therapeutic drug mimics the actions of natural incretin hormones, which play an important role in regulating blood sugar levels. By increasing insulin secretion and decreasing glucagon release, this medicine helps lower blood sugar after meals.
Besides controlling blood sugar levels, Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg Injection has shown potential to aid in weight loss, which is helpful for patients with obesity or other metabolic conditions. Usually, diabetic patients are prescribed Mounjaro along with a diet plan and exercise program when other oral anti-diabetes drugs do not achieve the desired blood sugar control. Patients with a history of medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 are not recommended to take this medication.
Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg Injection works by mimicking the actions of two vital hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones help regulate blood sugar by stimulating insulin release after food intake, reducing glucagon release, and slowing down gastric emptying. Along with lowering blood sugar, slowing down gastric emptying aids in feeling full for longer, contributing to weight reduction.
While effective, Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg Injection should be used with caution. Individuals with kidney or gastrointestinal complications should consult their healthcare provider (HCP) before start taking this medicine. Safety monitoring is necessary for thyroid tumors, pancreatitis, and serious hypoglycemia, mainly if used with other antidiabetic agents. Healthcare providers (HCPs) should assess individual risk factors before prescribing this medicine to ensure safe and effective treatment.
Dosage & Side Effects:
Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg Injection is available as a subcutaneous (SC) injection administered once weekly. The recommended starting dose is 2.5 mg injected once weekly, regardless of meal timing. On behalf of the patient’s response and tolerance, the dose may be increased to 5 mg after 4 weeks and further titrated up to a maximum of 15 mg weekly in case required. This injection is to be given into the abdomen, thigh, or upper arm, and it is best practice to rotate injection areas to avoid irritation. Missed doses should be taken as soon as they are remembered within four days, but in the event that they are not done, patients resume dosing as per their schedule. Patients must adhere to their doctor’s instructions regarding dose changes, especially after reported adverse effects or complications with blood sugar levels.The most common side effects of Mounjaro injection are nausea, diarrhea, decreased appetite, vomiting, dyspepsia, constipation, and abdominal pain.
